Paul J Clancy
CIK 1409601 · EVP, Chief Financial Officer · last filed 2026-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.76M
Companies
6
Total Filings
135
Lifetime Open-Market Net
-$49.98M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INCY | Director | 25,635 | $125.01 | $3.20M | -$1.42M | 44 | 2026-07-02 |
| SION | Director | — | $6.46 | — | $0 | 2 | 2026-06-18 |
| EXACT SCIENCES CORP (EXAS) Delisted | Director | 0 | $104.91 | $0 | $0 | 8 | 2026-03-23 |
| XLO | Director | — | $8.88 | — | $0 | 5 | 2025-06-12 |
| AGIO | Director | 6,549 | $34.21 | $224.0K | $0 | 12 | 2022-06-23 |
| BIIB | Executive VP and CFO | 10,813 | $216.04 | $2.34M | -$48.55M | 55 | 2017-04-27 |
Recent Filings · Page 4 of 14
135 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-04 | INCY | Grant (A) | +294 | $23.6K | EDGAR |
| 2022-10-04 | INCY | Grant (A) | +339 | $22.6K | EDGAR |
| 2022-07-01 | INCY | Grant (A) | +321 | $24.4K | EDGAR |
| 2022-06-23 | AGIO | Grant (A) | — | $0 | EDGAR |
| 2022-06-17 | XLO | Grant (A) | — | $0 | EDGAR |
| 2022-06-17 | INCY | Grant (A) | +2,144 | $0 | EDGAR |
| 2022-06-13 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +5,606 | $0 | EDGAR |
| 2022-05-24 | AGIO | Exer (M) | +1,585 | $0 | EDGAR |
| 2022-04-04 | INCY | Grant (A) | +326 | $25.9K | EDGAR |
| 2022-01-04 | INCY | Grant (A) | +343 | $25.2K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.